
TGA Names Cosmetic Injectables a Priority to 2027
The TGA's Compliance Principles 2026-27 names therapeutic goods used in cosmetic procedures, including dermal fillers and anti-wrinkle injectables, as a stated enforcement priority for the full two-year window. Across June and July 2026, two separate infringement actions against practitioners over unapproved injectable imports totalled $31,680 combined, with the TGA explicitly linking one action to this priority.